Scientists at the La Jolla Institute for Immunology have documented a robust antiviral immune response to SARS-CoV-2 in a group of 20 adults who had recovered from COVID-19.
Their work, published in today’s online edition of Cell, show that the body’s immune system is able to recognize SARS-CoV-2 in many ways, dispelling fears that the virus may elude ongoing efforts to create an effective vaccine.
The collaboration between the labs of Alessandro Sette and Shane Crotty, both professors at the institute’s Center for Infectious Disease and Vaccine Research, offers some good news for vaccine developers and is providing the first cellular immunology data to help guide social distancing recommendations.
Get the full story on our sister site, Drug Discovery & Development.
